Latest News about AMGN
Recent news which mentions AMGN
   Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis
   
  
  
  March 03, 2025
  From Benzinga
 
   Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform
   
  
  
  February 28, 2025
  From Benzinga
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  February 26, 2025
  From Benzinga
 
   These 3 Dow Jones Stocks Are Crushing It in 2025. Are They Still Buys?
   
  
  
  February 25, 2025
  From Motley Fool
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  February 11, 2025
  From Benzinga
 
   Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move
   
  
  
  February 10, 2025
  From Motley Fool
 
   3 Fabulous Dividend Stocks to Buy in February
   
  
  
  February 09, 2025
  From Motley Fool
 
   Uber To $80? Here Are 10 Top Analyst Forecasts For Thursday
   
  
  
  February 06, 2025
  From Benzinga
 
   Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
   
  
  
  February 05, 2025
  From Benzinga
 
   Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead
   
  
  
  February 05, 2025
  From Benzinga
 
   Amgen Options Trading: A Deep Dive into Market Sentiment
   
  February 05, 2025
  Tickers 
   AMGN
  
  
  From Benzinga
 
   These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025
   
  
  
  February 04, 2025
  From Motley Fool
 
   US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
   
  
  
  February 04, 2025
  From Benzinga
 
   Earnings Scheduled For February 4, 2025
   
  
  
  February 04, 2025
  From Benzinga
 
   These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024
   
  
  
  January 25, 2025
  From Motley Fool
 
   Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
   
  
  
  January 22, 2025
  From Benzinga
 From Motley Fool
 
   Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
   
  
  
  January 17, 2025
  From Benzinga
 
   FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
   
  
  
  January 17, 2025
  From Benzinga
 
   2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
   
  
  
  January 16, 2025
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.